Categories: All

by R G 12 years ago

489

B3: Respiratory Viruses

B3:  Respiratory Viruses

Respiratory

Herpes

HH6

Human Herpes 6

EBV

Epstein-Barr Virus

HSV

Herpes Simplex Virus

Adeno

High dose Ig

For the immunocompromised

Infection control

Fecal-oral route

Direct/Indirect contact with secretions

Year-round (Symbol = "around the clock")

Global

DNA hybridization
EM
Tissue/cell culture
Congenital/Neonatal
Disseminated

Ocular disease

CNS

Meningoencephalitis

GU

Orchitis

  • Inflammation of the testis
  • Rare
  • Hemorrhagic nephritis

    Hemorrhagic cystitis

    Hepatic necrosis

    Hepatitis

    Intussusception

    Mesenteric adenitis

    Acute GEitis

    Intranuclear inclusion bodies

    Serotypes

    Serotypes 40, 41

    These two serotypes do not grow well in tissue culture.

    47 infect humans

    100 types

    DS DNA
    Icosahedral
    Large

    Reo

    Paramyxo

    Others
    Mumps
    Measles (Rubeola)
    Human metapneumovirus
    Recent discovery
    Similar to RSV

    Differ by 2 structural proteins

    RSV

    Ribavirin

  • For complicated infections
  • Affects nucleic acid synthesis
  • Severely ill patient

    Mechanically ventilated

    Hypercarbic

    Hypoxic

    Immunocompromised

    Passive Immunity

    RSV monoclonal Ab

    RSV hyperimmune Ig

    Active Immunity

    Not commercially available

    Contagious

    Aerosol...

    Rapid Diagnostic

    Immunoassay

    Enzyme Immunoassay

    ELISA

    Enzyme-linked Immunosorbent Assay

    DFA

    Direct Immunofluorescence Assay

    Isolation in tissue culture

    CPE is syncytium formation

  • Syncytium formation w/in 3-8 days
  • CPE = cytopathic effect
  • Specimen

    Nasopharyngeal washing

    This method is preferred.

    Older Children/Adults

    Exacerbates asthma

    Infants/Children

    UR symptoms

    Neonates/Premies

    Lethargic

    Irritable

    Apnea

    Antigenic glycoprotein spikes

    Syncytium formation

    Fusion (F) glycoprotein

    Attachment

    G glycoprotein

    NONsegmented DNA

    Parainfluenza

    Antiviral?

  • Ribavirin effective in vitro
  • Hasn't been studied in clinical trials
  • Antibiotic

    Only for bacterial superinfections

    Croup

    Corticosteroids

    Nebulized racemic epinephrine

    Humidified air

    Vaccine NCA

    Vaccine is not commercially available

  • Killed vaccine ineffective
  • Live attenuated vaccine ineffective

  • Subunit vaccine promising
  • Intranasal vaccine promising
  • Wash Hands

    Spring / Early Summer

    Type 3

    Late Summer, Early fall

    Every other year

    Type 1

    Direct contact w/ secretions

    Fomites

    Serology

    Rapid diagnostic test

    EIA

    EIA = Enzyme immunoassay

    IF

    IF = Immunofluorescence assay

    Tissue or cell culture

    Less severe infection

    Which type? 1, 2, 3, or 4?

    Type 2

    Bronchiolitis

    Laryngotracheobronchitis (Croup)

    Laryngotracheitis

    Acute otitis media

    Glycoprotein envelope

    Fusion protein

    NONsegmented

    Antigenically stable

    No shifts or drifts

    Four types

    #1-4

    Orthomyxo

    Influenza

    Avoid Aspirin!

    Why?

    Reye's Syndrome

  • Viral release step
  • Neuraminidase inhibitor (Sialic acid analog)
  • Oseltamivir

  • Oral agent (O for Oral)
  • Influenza A (H1N2) --> much resistance
  • "Tamiflu"
  • Zanamivir

    Powdered inhaler

  • Prevents uncoating step
  • Targets M2 protein
  • Must be given w/in 48 hrs of symptoms
  • Ramantadine

    Amantadine

    Chemoprophylaxis

    Ramantidine

    Amantidine

    Vaccine

    Live attenuated

    NO Bell's Palsy

    Inactivated

    Intranasal

    Bell's Palsy

    Parenteral

    Parenteral = non-intestinal

    Definitive

    Serologic

    Enzyme immunoassay

    Neutralization

    Hemagglutinin inhibition

    Complement fixation

    ELISA or EIA (to detect Ag)

    Immunofluorescent stain

    Tissue or cell culture (hemadsorption)

    Inoculation of embryonated eggs

    Findings

    Pulmonary

    Wheezing

    Rhonchi

    Rales

    Fever

    Cervical adenopathy

    Rhinitis

    Conjunctivitis (mild)

    Symptoms

    Other

    Nonproductive cough

    Dizziness

    Myalgia

    Prostration (malaise)

    Chills

    Vomiting

    HEENT

    Eye irritation

    Nasal congestion

    Sore throat

    Complications

    Neurologic

    Guillain-Barre

    Transverse myelitis

    Encephalitis

    Bacterial superinfections

    Pneumonia

    Respiratory tract

    Reyes syndrome

    Acute myositis

    Type A, B, or C?

    Type B

    Cardiac

    Sudden Death

    Myocarditis

    Pericarditis

    Animal host potential reservoir

    Influenza Type A, B, or C?

    Influenza Type A

    Antigenic shifts

    lead to...

    Pandemic every 10 yrs.

    Annual midwinter epidemics

    Bacterial superinfection

    Edema + mononuclear cells

    Decreased mucous production

    Necrosis of nasal & tracheal ciliated epithelium

    Protein-surface spikes

    Drifts

    Major changes in H/N --> changes subtype

    Influenza A/B

    Shifts

    Minor changes in H/N, same subtype

    Influenza A ONLY

    Neuraminidase

    N1, N2

    Hemagglutinin

    H1, H2, H3

    Lipid-containing envelope

    Segmented

    allows for reassortment

    Pleomorphic

    3 Major Antigen types

    A, B, C

    Coronavirus

    Symptomatic

    Distinct winter peak in U.S.

    Seasonality varies

    Varies by

  • Location
  • Strain
  • Less useful

    Serologic assay

    Not helpful in diagnosing acute infection

    Tissue culture

    Difficult to isolate

    Based on clinical syndrome

    SARS

    Epi

    Droplet-nuclei

    Asia

    Diarrhea

    Body aches

    High fever

    Headache

    GI

    Watery diarrhea

    No blood

    LR

    LR = Lower respiratory

    Precipitate an acute asthma attack

    Pneumonia in infants

    UR

    UR = Upper respiratory

    Pharyngitis

    Common cold

    Virulent strains

    OC43

    229E

    3 Major Antigens

    2 Envelope proteins

    Nucleocapsid

    Peplomers

    Solar corona appearance

    Distinct spikes

    Picorna

    Enterovirus
    Rhinovirus
    Treatment

    Interferon effective

    No specific antiviral

    Symptomatic (Decongestants)

    Prevention

    Resistant to common disinfectants

    Think NAKED DNA

    Good hygiene

    No vaccine

    Epidemiology

    Transmission

    Aerosolization

    P2P

    Person to person

    Acute resp. illness

    Common Cold

    30-50%

    Person

    Incidence highest in young children

    Place

    Temperate climates

    Time

    Spring to Early Fall

    "Summer colds"

    Diagnosis

    Defenitive

    Serum Ab

    Not helpful in acute disease

    Tissue culture (impractical)

    Presumptive

    Based on

  • Clinical presentation
  • Season
  • Clinical

    Sequelae

    Sinusitis

    Otitis media

    Exacerbation of asthma

    Children / Adults

    Afebrile, UR

    Young Infants

    Febrile, UR

    Characteristics

    Pathophysiology

    Other facts

  • Incubation period 2 to 3 days (up to 7 days)
  • Viral replication peaks in respiratory tract at day 2 to 3 (may shed up to 1 month)
  • Serum Ab (1 mo.)

    Specific IgA Ab (1 wk.)

    Related to Poliovirus, Enterovirus

    100+ serotypes

    CPE similar to other Picornavirus

    Grows at 33 degrees C

    Acid labile

    Gold flag = Distinguishing characteristic